Ongoing Litigation Regarding the Use of Cow’s Milk Formulas and Necrotizing Enterocolitis: Issues of Product Liability and Proposed Requirement for Informed Consent
Breastfeeding Medicine · 2025
DOI: 10.1089/bfm.2024.0321 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breastfeeding Medicine, 2025. Verfasst von T Allen Merritt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Neonatology, Loma Linda University School of Medicine, Loma Linda, California, USA. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Infant Formula, Informed Consent, Liability, Legal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Recent litigation against the two major U.S. formula manufacturers regarding their products liability, in Gill v Abbott Laboratories and Watson v Mead Johnson, juries in two U.S. states have determined that these manufacturers’ created products liability by their failure to warn parents and medical professionals that their formulas posed an increased risk for necrotizing enterocolitis (NEC). They asserted that their products are safe and effective. Juries in state courts in both cases awarded substantial monetary awards for punitive damage, economic and emotional harms to parents whose infant died after being fed “premature special care formulas.” The company’s defense attorneys unsuccessfully asserted the doctrine of learned intermediaries, namely that it was neonatologists who ordered and/or administered these products to premature infants, thus causing NEC. The Food and Drug Administration (FDA) has regulatory authority over the formula manufacturing processes but does not grant “approval” status, as the FDA classifies these “special care formulas” as exempt because they are nutritional agents. While both cases are being appealed, the impact of these legal actions may discourage further “special care formula” development and may pose the future risk of physician malpractice allegations when an infant develops NEC after receiving a “special care formula.” In accordance with American Academy of Pediatrics recommendations, obtaining informed consent for formula use may mitigate some legal risks for neonatologists and other medical providers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Neonatology, Loma Linda University School of Medicine, Loma Linda, California, USA.
- Division of Neonatology, Evanston, Hospital, Endeavor Health, Evanston, Illinois, USA.
ORCID-Profile: T Allen Merritt
Zitieren
APA
Merritt, T. A., Hillyer, K., Goldstein, M., & Hageman, J. (2025). Ongoing Litigation Regarding the Use of Cow’s Milk Formulas and Necrotizing Enterocolitis: Issues of Product Liability and Proposed Requirement for Informed Consent. Breastfeeding Medicine. https://doi.org/10.1089/bfm.2024.0321
Vancouver
Merritt TA, Hillyer K, Goldstein M, Hageman J. Ongoing Litigation Regarding the Use of Cow’s Milk Formulas and Necrotizing Enterocolitis: Issues of Product Liability and Proposed Requirement for Informed Consent. Breastfeeding Medicine. 2025. doi:10.1089/bfm.2024.0321
BibTeX
@article{Merritt2025,
author = {Merritt, T Allen and Hillyer, Kimberly and Goldstein, Mitchell and Hageman, Joseph},
title = {Ongoing Litigation Regarding the Use of Cow’s Milk Formulas and Necrotizing Enterocolitis: Issues of Product Liability and Proposed Requirement for Informed Consent},
journal = {Breastfeeding Medicine},
year = {2025},
doi = {10.1089/bfm.2024.0321}
}
EUVIMED